{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T06:48:33Z","timestamp":1770014913936,"version":"3.49.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,10]]},"DOI":"10.1212\/wnl.51.4.1069","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:36:31Z","timestamp":1336916191000},"page":"1069-1074","source":"Crossref","is-referenced-by-count":81,"title":["Tourette's syndrome"],"prefix":"10.1212","volume":"51","author":[{"given":"A.","family":"Heinz","sequence":"first","affiliation":[{"name":"From the Clinical Brain Disorders Branch (Drs. Heinz, Wolf, Jones, Gorey, Hyde, and Weinberger), Intramural Research Program, National Institute of Mental Health (NIMH), National Institutes of Health, NIMH Neuroscience Center, St. Elizabeths Hospital, Washington, DC; and the Stanley Foundation Research Programs (Dr. Knable), Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. B.","family":"Knable","sequence":"additional","affiliation":[{"name":"From the Clinical Brain Disorders Branch (Drs. Heinz, Wolf, Jones, Gorey, Hyde, and Weinberger), Intramural Research Program, National Institute of Mental Health (NIMH), National Institutes of Health, NIMH Neuroscience Center, St. Elizabeths Hospital, Washington, DC; and the Stanley Foundation Research Programs (Dr. Knable), Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. S.","family":"Wolf","sequence":"additional","affiliation":[{"name":"From the Clinical Brain Disorders Branch (Drs. Heinz, Wolf, Jones, Gorey, Hyde, and Weinberger), Intramural Research Program, National Institute of Mental Health (NIMH), National Institutes of Health, NIMH Neuroscience Center, St. Elizabeths Hospital, Washington, DC; and the Stanley Foundation Research Programs (Dr. Knable), Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. W.","family":"Jones","sequence":"additional","affiliation":[{"name":"From the Clinical Brain Disorders Branch (Drs. Heinz, Wolf, Jones, Gorey, Hyde, and Weinberger), Intramural Research Program, National Institute of Mental Health (NIMH), National Institutes of Health, NIMH Neuroscience Center, St. Elizabeths Hospital, Washington, DC; and the Stanley Foundation Research Programs (Dr. Knable), Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. G.","family":"Gorey","sequence":"additional","affiliation":[{"name":"From the Clinical Brain Disorders Branch (Drs. Heinz, Wolf, Jones, Gorey, Hyde, and Weinberger), Intramural Research Program, National Institute of Mental Health (NIMH), National Institutes of Health, NIMH Neuroscience Center, St. Elizabeths Hospital, Washington, DC; and the Stanley Foundation Research Programs (Dr. Knable), Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. M.","family":"Hyde","sequence":"additional","affiliation":[{"name":"From the Clinical Brain Disorders Branch (Drs. Heinz, Wolf, Jones, Gorey, Hyde, and Weinberger), Intramural Research Program, National Institute of Mental Health (NIMH), National Institutes of Health, NIMH Neuroscience Center, St. Elizabeths Hospital, Washington, DC; and the Stanley Foundation Research Programs (Dr. Knable), Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. R.","family":"Weinberger","sequence":"additional","affiliation":[{"name":"From the Clinical Brain Disorders Branch (Drs. Heinz, Wolf, Jones, Gorey, Hyde, and Weinberger), Intramural Research Program, National Institute of Mental Health (NIMH), National Institutes of Health, NIMH Neuroscience Center, St. Elizabeths Hospital, Washington, DC; and the Stanley Foundation Research Programs (Dr. Knable), Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520250012002"},{"key":"e_1_3_1_3_2","unstructured":"Swedo SE Leonard HL. Childhood movement disorders and obsessive compulsive disorder. J Clin Psychiatry 1994;55(suppl):32-37."},{"key":"e_1_3_1_4_2","first-page":"8","volume":"50","year":"1993","unstructured":"Cummings JL. Frontal-subcortical circuits and motor behavior. Arch Neurol 1993;50:873-880.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_5_2","first-page":"2","volume":"44","year":"1987","unstructured":"Baxter LR, Phleps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Arch Gen Psychiatry 1987;44:211-218.","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_3_1_6_2","first-page":"6","volume":"9","year":"1992","unstructured":"Baxter LR, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992;9:681-689.","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.1.1"},{"key":"e_1_3_1_8_2","first-page":"2","volume":"35","year":"1978","unstructured":"Cohen DJ, Shaywitz BA, Caparulo BK, Young JG, Bowers MB. Chronic multiple tics of Gilles de la Tourette's syndrome: CSF acid monoamine metabolites after probenecid administration. Arch Gen Psychiatry 1978;35:245-250.","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_3_1_9_2","first-page":"3","volume":"12","year":"1979","unstructured":"Singer HS, Butler IJ, Tune LE, Seifert WE, Coyle JT. Dopaminergic dysfunction in Tourette syndrome. Ann Neurol 1979;12:361-366.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.1.1"},{"key":"e_1_3_1_11_2","first-page":"1","volume":"273","year":"1996","unstructured":"Wolf SS, Jones DW, Knable MB, et al. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 1996;273:1225-1227.","journal-title":"Science"},{"key":"e_1_3_1_12_2","first-page":"3","volume":"14","year":"1994","unstructured":"Frankenburg FR, Kando JC. Sertraline treatment of attention deficit hyperactivity disorder and Tourette's syndrome. J Clin Psychopharmacol 1994;14:359-360.","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_3_1_13_2","first-page":"7","volume":"20","year":"1996","unstructured":"Eapen V, Trimble MR, Robertson MM. The use of fluoxetine in Gilles de la Tourette syndrome and obsessive compulsive behaviours: preliminary clinical experience. Prog Neuropsychopharmacol Biol Psychiatry 1996;20:737-743.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"e_1_3_1_14_2","first-page":"6","volume":"10","year":"1995","unstructured":"Hauser RA, Zesiewicz TA. Sertraline-induced exacerbation of tics in Tourette's syndrome. Mov Disord 1995;10:682-683.","journal-title":"Mov Disord"},{"key":"e_1_3_1_15_2","unstructured":"McDougle CJ Goodman WK Price LH. Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J Clin Psychiatry 1994;55(suppl):24-31."},{"key":"e_1_3_1_16_2","unstructured":"Goetz CG. Clonidine and clonazepam in Tourette syndrome. In: Chase TN Friedhoff AJ Cohen DJ eds. Advances in neurology vol. 58. New York: Raven Press 1992;245-251."},{"key":"e_1_3_1_17_2","first-page":"9","volume":"16","year":"1994","unstructured":"Farde L, Halldin C, Mueller L, Suhara T, Karlsson P, Hall H. PET study of [C-11] \u03b2-CIT binding to monoamine transporters in the monkey and human brain. Synapse 1994;16:93-103.","journal-title":"Synapse"},{"key":"e_1_3_1_18_2","first-page":"2","volume":"13","year":"1993","unstructured":"Laruelle M, Baldwin RM, Malison RT, et al. SPECT imaging of dopamine and serotonin transporters with [123-I]\u03b2-CIT: pharmacological characterization of brain uptake in non-human primates. Synapse 1993;13:295-309.","journal-title":"Synapse"},{"key":"e_1_3_1_19_2","first-page":"1","volume":"50","year":"1993","unstructured":"The Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders. Arch Neurol 1993;50:1013-1016.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_20_2","first-page":"5","volume":"28","year":"1989","unstructured":"Leckman J, Riddle M, Hardin M, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Psychiatry 1989;28:566-573.","journal-title":"J Am Acad Child Psychiatry"},{"key":"e_1_3_1_21_2","unstructured":"Kurlan R Riddle M Como P. Tourette Syndrome Association Unified Tic Rating Scale. Version 2.0. New York: Tourette Syndrome Association 1990."},{"key":"e_1_3_1_22_2","first-page":"5","volume":"5","year":"1993","unstructured":"Baldwin RM, Zea-Ponce Y, Zoghbi SS, et al. Evaluation of the monoamine uptake site ligand [123-I]methyl 3\u03b2-(iodophenyl)-tropane-2\u03b2-carboxylate ([123-I]\u03b2-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI. Nucl Med Biol 1993;5:597-606.","journal-title":"Nucl Med Biol"},{"key":"e_1_3_1_23_2","first-page":"9","volume":"14","year":"1994","unstructured":"Laruelle M, Wallace E, Seibyl JP, et al. Graphical, kinetic, and equilibrium analyses of in vivo [123-I]\u03b2-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 1994;14:982-994.","journal-title":"J Cereb Blood Flow Metab"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.48.1.1"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.3109\/00207458808985773"},{"key":"e_1_3_1_26_2","first-page":"5","volume":"40","year":"1983","unstructured":"Devinsky O. Neuroanatomy of Gilles de la Tourette's syndrome. Possible midbrain involvement. Arch Neurol 1983;40:508-514.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_27_2","unstructured":"Richardson EP. Neuropathological studies of Tourette syndrome. In: Friedhoff AJ Chase TN eds. Gilles de la Tourette syndrome. New York: Raven Press 1982:83-87."},{"key":"e_1_3_1_28_2","first-page":"2","volume":"77","year":"1987","unstructured":"Wirtshafter D, Stratford TR, Asin KE. Evidence that serotonergic projections to the substantia nigra in the rat arise in the dorsal, but not the median, raphe nucleus. Neurosci Lett 1987;77:261-266.","journal-title":"Neurosci Lett"},{"key":"e_1_3_1_29_2","first-page":"4","volume":"55","year":"1993","unstructured":"Corvaja N, Doucet G, Bolam JP. Ultrastructure and synaptic targets of the raphe-nigral projection in the rat. Neuroscience 1993;55:417-427.","journal-title":"Neuroscience"},{"key":"e_1_3_1_30_2","first-page":"2","volume":"73","year":"1996","unstructured":"Sur C, Betz H, Schloss P. Immunochemical detection of the serotonin transporter in rat brain. Neuroscience 1996;73:217-231.","journal-title":"Neuroscience"},{"key":"e_1_3_1_31_2","first-page":"2","volume":"76","year":"1996","unstructured":"Brodie MS, Bunney EB. Serotonin potentiates dopamine inhibition of ventral tegmental area neurons in vitro. J Neurophysiol 1996;76:2077-2082.","journal-title":"J Neurophysiol"},{"key":"e_1_3_1_32_2","first-page":"8","volume":"15","year":"1995","unstructured":"Dewey SL, Smith GS, Logan J, et al. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J Neurosci 1995;15:821-829.","journal-title":"J Neurosci"},{"key":"e_1_3_1_33_2","first-page":"5","volume":"31","year":"1993","unstructured":"Kelland MD, Freeman AS, Rubin J, Chiodo LA. Ascending afferent regulation of rat midbrain dopamine neurons. Brain Res Bull 1993;31:539-546.","journal-title":"Brain Res Bull"},{"key":"e_1_3_1_34_2","first-page":"6","volume":"84","year":"1993","unstructured":"Trent F, Tepper JM. Dorsal raphe stimulation modifies striatal-evoked antidromic invasion of nigral dopaminergic neurons in vivo. Exp Brain Res 1993;84:620-630.","journal-title":"Exp Brain Res"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004691-199201000-00002"},{"key":"e_1_3_1_36_2","first-page":"3","volume":"2","year":"1995","unstructured":"Storozhuk VM, Sachenko VV, Kruchenko JA. Dependence of sensorimotor cortex neuron activity on noradrenergic and serotonergic transmission in unspecific thalamic nuclei. Neuroscience 1995;2:315-322.","journal-title":"Neuroscience"},{"key":"e_1_3_1_37_2","first-page":"2","volume":"365","year":"1996","unstructured":"Kia HK, Miquel MC, Brisorgueil MJ, et al. Immunocytochemical localization of serotonin 1A receptors in the rat central nervous system. J Comp Neurol 1996;365:289-305.","journal-title":"J Comp Neurol"},{"key":"e_1_3_1_38_2","first-page":"7","volume":"15","year":"1995","unstructured":"Sadzot B, Lemaire C, Maquet P, et al. Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [F-18]altanserin: results in young normal control subjects. J Cereb Blood Flow Metab 1995;15:787-797.","journal-title":"J Cereb Blood Flow Metab"},{"key":"e_1_3_1_39_2","first-page":"6","volume":"117","year":"1996","unstructured":"Gustafson EL, Durkin MM, Bard JA, Zgombick J, Branchek TA. A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-HT7 receptor in rat brain. Br J Pharmacol 1996;117:657-666.","journal-title":"Br J Pharmacol"},{"key":"e_1_3_1_40_2","first-page":"2","volume":"66","year":"1996","unstructured":"Heils A, Teufel A, Petri S, et al. Allelic variation in the human serotonin transporter gene expression. J Neurochem 1996;66:2621-2624.","journal-title":"J Neurochem"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.51.4.1069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:39:09Z","timestamp":1711550349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.51.4.1069"}},"subtitle":["[I-123]\u03b2-CIT SPECT correlates of vocal tic severity"],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["10.1212\/WNL.51.4.1069"],"URL":"https:\/\/doi.org\/10.1212\/wnl.51.4.1069","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}